Literature DB >> 17722107

The role of chromosomal alterations in human cancer development.

Patrizia Gasparini1, Gabriella Sozzi, Marco A Pierotti.   

Abstract

Cancer cells become unstable and compromised because several cancer-predisposing mutations affect genes that are responsible for maintaining the genomic instability. Several factors influence the formation of chromosomal rearrangements and consequently of fusion genes and their role in tumorigenesis. Studies over the past decades have revealed that recurring chromosome rearrangements leading to fusion genes have a biological and clinical impact not only on leukemias and lymphomas, but also on certain epithelial tumors. With the implementation of new and powerful cytogenetic and molecular techniques the identification of fusion genes in solid tumors is being facilitated. Overall, the study of chromosomal translocations have revealed several recurring themes, and reached important insights into the process of malignant transformation. However, the mechanisms behind these translocations remain unclear. A more thorough understanding of the mechanisms that cause translocations will be aided by continuing characterization of translocation breakpoints and by developing in vitro and in vivo model systems that can generate chromosome translocation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17722107     DOI: 10.1002/jcb.21481

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  16 in total

1.  Laser excitation power and the flow cytometric resolution of complex karyotypes.

Authors:  Bee L Ng; Nigel P Carter
Journal:  Cytometry A       Date:  2010-06       Impact factor: 4.355

2.  DNA fragile site breakage as a measure of chemical exposure and predictor of individual susceptibility to form oncogenic rearrangements.

Authors:  Christine E Lehman; Laura W Dillon; Yuri E Nikiforov; Yuh-Hwa Wang
Journal:  Carcinogenesis       Date:  2017-03-01       Impact factor: 4.944

3.  Different aneuploidies arise from the same bridge-induced chromosomal translocation event in Saccharomyces cerevisiae.

Authors:  Beatrice Rossi; Pawan Noel; Carlo V Bruschi
Journal:  Genetics       Date:  2010-08-30       Impact factor: 4.562

4.  RNA-Seq for the detection of gene fusions in solid tumors: development and validation of the JAX FusionSeq™ 2.0 assay.

Authors:  Daniel Bergeron; Harshpreet Chandok; Qian Nie; Matthew Prego; Melissa Soucy; Kevin Kelly; Guruprasad Ananda; Andrew Hesse; Honey V Reddi
Journal:  J Mol Med (Berl)       Date:  2022-01-10       Impact factor: 4.599

Review 5.  Oncogenic gene fusions in epithelial carcinomas.

Authors:  John R Prensner; Arul M Chinnaiyan
Journal:  Curr Opin Genet Dev       Date:  2009-02-21       Impact factor: 5.578

6.  Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.

Authors:  Huiling He; Wei Li; Pearlly Yan; Ralf Bundschuh; Jackson A Killian; Jadwiga Labanowska; Pamela Brock; Rulong Shen; Nyla A Heerema; Albert de la Chapelle
Journal:  Thyroid       Date:  2018-05-16       Impact factor: 6.568

7.  Frequent aneuploidy among normal human hepatocytes.

Authors:  Andrew W Duncan; Amy E Hanlon Newell; Leslie Smith; Elizabeth M Wilson; Susan B Olson; Matthew J Thayer; Stephen C Strom; Markus Grompe
Journal:  Gastroenterology       Date:  2011-11-02       Impact factor: 22.682

8.  Dominant-negative mechanism of leukemogenic PAX5 fusions.

Authors:  N Kawamata; M A Pennella; J L Woo; A J Berk; H P Koeffler
Journal:  Oncogene       Date:  2011-07-18       Impact factor: 9.867

9.  Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma.

Authors:  Elisa Menicali; Sonia Moretti; Pasquale Voce; Serena Romagnoli; Nicola Avenia; Efisio Puxeddu
Journal:  Front Endocrinol (Lausanne)       Date:  2012-05-22       Impact factor: 5.555

10.  DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells.

Authors:  M Gandhi; L W Dillon; S Pramanik; Y E Nikiforov; Y-H Wang
Journal:  Oncogene       Date:  2010-01-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.